RE CFO

Company

BioRestorative Therapies, Inc.

Filed

December 8, 2021

Period of Report

December 3, 2021

Accession Number

0001021771-21-000099

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →